224 related articles for article (PubMed ID: 37776423)
1. Identifying the effectiveness of 3D culture systems to recapitulate breast tumor tissue in situ.
Ludwik KA; Greathouse FR; Han S; Stauffer K; Brenin DR; Stricker TP; Lannigan DA
Cell Oncol (Dordr); 2024 Apr; 47(2):481-496. PubMed ID: 37776423
[TBL] [Abstract][Full Text] [Related]
2. The potential application of organoids in breast cancer research and treatment.
Ebrahimi N; Nasr Esfahani A; Samizade S; Mansouri A; Ghanaatian M; Adelian S; Shadman Manesh V; Hamblin MR
Hum Genet; 2022 Feb; 141(2):193-208. PubMed ID: 34713317
[TBL] [Abstract][Full Text] [Related]
3. Advantages and limitations of 3D organoids and ex vivo tumor tissue culture in personalized medicine for prostate cancer.
Mickova A; Morong M; Levková M; Kurfúrstová D; Kharaishvili G; Überall I; Student V; Student V; Drapela S; Soucek K; Bouchal J
Klin Onkol; 2022; 35(6):473-481. PubMed ID: 36513514
[TBL] [Abstract][Full Text] [Related]
4. Breast tumour organoids: promising models for the genomic and functional characterisation of breast cancer.
Roelofs C; Hollande F; Redvers R; Anderson RL; Merino D
Biochem Soc Trans; 2019 Feb; 47(1):109-117. PubMed ID: 30626705
[TBL] [Abstract][Full Text] [Related]
5. Establishment of patient-derived organoids for guiding personalized therapies in breast cancer patients.
Wu H; Wang W; Zhang Y; Chen Y; Shan C; Li J; Jia Y; Li C; Du C; Cai Y; Zhang Y; Zhang S; Wu F
Int J Cancer; 2024 Jul; 155(2):324-338. PubMed ID: 38533706
[TBL] [Abstract][Full Text] [Related]
6. 3D modeling in cancer studies.
Atat OE; Farzaneh Z; Pourhamzeh M; Taki F; Abi-Habib R; Vosough M; El-Sibai M
Hum Cell; 2022 Jan; 35(1):23-36. PubMed ID: 34761350
[TBL] [Abstract][Full Text] [Related]
7. Bioengineering Approaches for the Advanced Organoid Research.
Yi SA; Zhang Y; Rathnam C; Pongkulapa T; Lee KB
Adv Mater; 2021 Nov; 33(45):e2007949. PubMed ID: 34561899
[TBL] [Abstract][Full Text] [Related]
8. Long-term culture, genetic manipulation and xenotransplantation of human normal and breast cancer organoids.
Dekkers JF; van Vliet EJ; Sachs N; Rosenbluth JM; Kopper O; Rebel HG; Wehrens EJ; Piani C; Visvader JE; Verissimo CS; Boj SF; Brugge JS; Clevers H; Rios AC
Nat Protoc; 2021 Apr; 16(4):1936-1965. PubMed ID: 33692550
[TBL] [Abstract][Full Text] [Related]
9. Exploring the interaction between extracellular matrix components in a 3D organoid disease model to replicate the pathophysiology of breast cancer.
Bhattacharya A; Alam K; Roy NS; Kaur K; Kaity S; Ravichandiran V; Roy S
J Exp Clin Cancer Res; 2023 Dec; 42(1):343. PubMed ID: 38102637
[TBL] [Abstract][Full Text] [Related]
10. Gene expressions and their significance in organoid cultures obtained from breast cancer patient-derived biopsies.
Pranav P; Palaniyandi T; Baskar G; Ravi M; Rajendran BK; Sivaji A; Ranganathan M
Acta Histochem; 2022 Jul; 124(5):151910. PubMed ID: 35667159
[TBL] [Abstract][Full Text] [Related]
11. Tissue mimetic 3D scaffold for breast tumor-derived organoid culture toward personalized chemotherapy.
Nayak B; Balachander GM; Manjunath S; Rangarajan A; Chatterjee K
Colloids Surf B Biointerfaces; 2019 Aug; 180():334-343. PubMed ID: 31075687
[TBL] [Abstract][Full Text] [Related]
12. Organoids: An intermediate modeling platform in precision oncology.
Jin MZ; Han RR; Qiu GZ; Ju XC; Lou G; Jin WL
Cancer Lett; 2018 Feb; 414():174-180. PubMed ID: 29174804
[TBL] [Abstract][Full Text] [Related]
13. Tumor organoids: applications in cancer modeling and potentials in precision medicine.
Xu H; Jiao D; Liu A; Wu K
J Hematol Oncol; 2022 May; 15(1):58. PubMed ID: 35551634
[TBL] [Abstract][Full Text] [Related]
14. Appendiceal Cancer Patient-Specific Tumor Organoid Model for Predicting Chemotherapy Efficacy Prior to Initiation of Treatment: A Feasibility Study.
Votanopoulos KI; Mazzocchi A; Sivakumar H; Forsythe S; Aleman J; Levine EA; Skardal A
Ann Surg Oncol; 2019 Jan; 26(1):139-147. PubMed ID: 30414038
[TBL] [Abstract][Full Text] [Related]
15. Organoid Cultures Derived From Patients With Papillary Thyroid Cancer.
Chen D; Tan Y; Li Z; Li W; Yu L; Chen W; Liu Y; Liu L; Guo L; Huang W; Zhao Y
J Clin Endocrinol Metab; 2021 Apr; 106(5):1410-1426. PubMed ID: 33524147
[TBL] [Abstract][Full Text] [Related]
16. Breast cancer organoids from malignant pleural effusion-derived tumor cells as an individualized medicine platform.
Pan B; Zhao D; Liu Y; Li N; Song C; Li N; Li X; Zhao Z
In Vitro Cell Dev Biol Anim; 2021 May; 57(5):510-518. PubMed ID: 33950403
[TBL] [Abstract][Full Text] [Related]
17. Patient derived organoids in prostate cancer: improving therapeutic efficacy in precision medicine.
Pamarthy S; Sabaawy HE
Mol Cancer; 2021 Sep; 20(1):125. PubMed ID: 34587953
[TBL] [Abstract][Full Text] [Related]
18. Establishment of Pancreatic Organoids from Normal Tissue and Tumors.
Driehuis E; Gracanin A; Vries RGJ; Clevers H; Boj SF
STAR Protoc; 2020 Dec; 1(3):100192. PubMed ID: 33377086
[TBL] [Abstract][Full Text] [Related]
19. Characterization of organoid cultured human breast cancer.
Goldhammer N; Kim J; Timmermans-Wielenga V; Petersen OW
Breast Cancer Res; 2019 Dec; 21(1):141. PubMed ID: 31829259
[TBL] [Abstract][Full Text] [Related]
20. Standardization of organoid culture in cancer research.
Zhou C; Wu Y; Wang Z; Liu Y; Yu J; Wang W; Chen S; Wu W; Wang J; Qian G; He A
Cancer Med; 2023 Jul; 12(13):14375-14386. PubMed ID: 37081739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
